Author:
Scaggiante Bruna,Dapas Barbara,Farra Rossella,Tonon Federica,Abrami Michela,Grassi Mario,Musiani Francesco,Zanconati Fabrizio,Pozzato Gabriele,Grassi Gabriele
Reference119 articles.
1. Althausen S, Mengesdorf T, Mies G, Olah L, Nairn AC, Proud CG, Paschen W (2001) Changes in the phosphorylation of initiation factor eIF-2alpha, elongation factor eEF-2 and p70 S6 kinase after transient focal cerebral ischaemia in mice. J Neurochem 78:779–787
2. Andersen CB, Becker T, Blau M, Anand M, Halic M, Balar B, Mielke T, Boesen T, Pedersen JS, Spahn CM, Kinzy TG, Andersen GR, Beckmann R (2006) Structure of eEF3 and the mechanism of transfer RNA release from the E-site. Nature 443:663–668
3. Arora S, Yang JM, Kinzy TG, Utsumi R, Okamoto T, Kitayama T, Ortiz PA, Hait WN (2003) Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines. Cancer Res 63:6894–6899
4. Bektas M, Nurten R, Gurel Z, Sayers Z, Bermek E (1994) Interactions of eukaryotic elongation factor 2 with actin: a possible link between protein synthetic machinery and cytoskeleton. FEBS Lett 356:89–93
5. Blanch A, Robinson F, Watson IR, Cheng LS, Irwin MS (2013) Eukaryotic translation elongation factor 1-alpha 1 inhibits p53 and p73 dependent apoptosis and chemotherapy sensitivity. PLoS ONE 8:e66436
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献